[go: up one dir, main page]

AU2001269106A1 - Novel alpha expressed in heart and testis - Google Patents

Novel alpha expressed in heart and testis

Info

Publication number
AU2001269106A1
AU2001269106A1 AU2001269106A AU6910601A AU2001269106A1 AU 2001269106 A1 AU2001269106 A1 AU 2001269106A1 AU 2001269106 A AU2001269106 A AU 2001269106A AU 6910601 A AU6910601 A AU 6910601A AU 2001269106 A1 AU2001269106 A1 AU 2001269106A1
Authority
AU
Australia
Prior art keywords
testis
heart
novel alpha
alpha expressed
expressed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269106A
Inventor
Steven Goossens
Barbara Janssens
Frans Van Roy
Griet Vanpoucke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vlaams Instituut voor Biotechnologie VIB
Original Assignee
Vlaams Instituut voor Biotechnologie VIB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Instituut voor Biotechnologie VIB filed Critical Vlaams Instituut voor Biotechnologie VIB
Publication of AU2001269106A1 publication Critical patent/AU2001269106A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001269106A 2000-07-12 2001-06-28 Novel alpha expressed in heart and testis Abandoned AU2001269106A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP00202472 2000-07-12
EP00202472 2000-07-12
US21830900P 2000-07-14 2000-07-14
US60218309 2000-07-14
PCT/EP2001/007392 WO2002004636A1 (en) 2000-07-12 2001-06-28 NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS

Publications (1)

Publication Number Publication Date
AU2001269106A1 true AU2001269106A1 (en) 2002-01-21

Family

ID=26072486

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269106A Abandoned AU2001269106A1 (en) 2000-07-12 2001-06-28 Novel alpha expressed in heart and testis

Country Status (4)

Country Link
US (1) US7341866B2 (en)
EP (1) EP1299536B1 (en)
AU (1) AU2001269106A1 (en)
WO (1) WO2002004636A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1299536B1 (en) 2000-07-12 2013-03-27 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Antibody and uses relating to alpha-t catenin
CN110305209B (en) * 2019-07-09 2022-09-13 福建医科大学附属第一医院 Polypeptide for treating malignant tumor and application thereof as vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06211898A (en) * 1992-12-25 1994-08-02 Takara Shuzo Co Ltd Neural alpha-catenin
WO1996002002A1 (en) * 1994-07-08 1996-01-25 Schalken Jack A Assay for increased invasiveness of epithelial cells
US6551994B1 (en) * 1997-04-10 2003-04-22 Mcgill University Compounds and methods for inhibiting the interaction between α-catenin and β-catenin
EP1299536B1 (en) 2000-07-12 2013-03-27 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Antibody and uses relating to alpha-t catenin

Also Published As

Publication number Publication date
EP1299536A1 (en) 2003-04-09
WO2002004636A1 (en) 2002-01-17
US7341866B2 (en) 2008-03-11
US20030165506A1 (en) 2003-09-04
EP1299536B1 (en) 2013-03-27
WO2002004636A8 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
AU2001292053A1 (en) Improvements in and relating to hat decorations
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2001264258A1 (en) Nonwoven-fabric laminate and use thereof
AU2002211717A1 (en) Stresscopins and their uses
AU2001261750A1 (en) Laminate and its use
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2121200A (en) Improvements in or relating to sphygmomanometers and other devices
AU7458201A (en) Laminate and use thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU4427201A (en) Noise-abatement structure and its constituting elements
AU2002221353A1 (en) Suitcase structure and suitcase incorporating same
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU1041801A (en) Improvements in or relating to an infuser
AU2001269106A1 (en) Novel alpha expressed in heart and testis
AU2002256556A1 (en) Sea-trosy and related methods
AU5979300A (en) Angiopoietin-6 and uses thereof
AU2001277519A1 (en) Bio-probes and use thereof
AU2001252621A1 (en) Novel proetin and use thereof
AU2001272638A1 (en) Hand and wrist support
AU2002221222A1 (en) Novel method and use
AU2002214307A1 (en) T cell line and use thereof
AU5854801A (en) Improvements in and relating to telecommunications
AU2001256680A1 (en) Hiv-producing cell line and use thereof